Acute Coronary Syndrome Clinical Trials in Minneapolis, Minnesota
2 recruitingMinneapolis, Minnesota
Showing 1–2 of 2 trials
Recruiting
Phase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
DalCor Pharmaceuticals2,000 enrolled223 locationsNCT05918861
Recruiting
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
Acute Coronary SyndromeCardiogenic Shock
University of Minnesota200 enrolled1 locationNCT05426083